Blood test may forecast kidney comeback in dialysis emergencies

NCT ID NCT07637435

Completed Knowledge-focused Sponsor: Muğla Sıtkı Koçman University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study looked at 170 adults who needed emergency hemodialysis for acute kidney injury. Researchers measured three blood markers (Activin A, Nostrin, and Angiopoetin-2) before dialysis to see if they could predict whether the kidneys would recover or if the patient would die within 6 months. The goal is to find simple blood tests that help doctors make better treatment decisions for these critically ill patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this research could help doctors better predict which patients will recover kidney function and who is at higher risk of dying.
What could go wrong: This is an observational study, not a treatment trial. The markers may not prove useful in real-world settings, and results may not apply to all kidney injury patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute kidney injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE KIDNEY INJURY HEMODIALYSIS

Contacts and locations

Locations

Mugla Sitki Kocman University

Muğla, Menteşe, 48000, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.